Neptune Technologies Receives Approval For NASDAQ Listing

Company on Track to Achieve Goals Consistent with Business Plan

Laval, Québec, CANADA – August 09, 2007 – Neptune Technologies & Bioressources Inc. (NASDAQ.NEPT - TSX.V.NTB) announced today that its common shares have been approved for listing on The NASDAQ Capital Market under the symbol NEPT and will begin trading on August 13, 2007. Neptune Technologies & Bioressources (NTB) extracts, scientifically validates, and markets scientifically validated health ingredients extracted from marine biomasses; the Company currently provides the world’s only FDA-allowed oil from krill.

“We’re extremely gratified to have reached this major milestone,” stated Mr.André Godin, Neptune Vice-President, Administration and Finance. “As identified in our business plan and consistently communicated by management, we have intended to obtain a listing for Neptune Technologies securities on a stock exchange in the United States. Following a comprehensive evaluation of the U.S. exchanges, we determined that the NASDAQ Capital Market was the best fit for Neptune Technologies,” Mr. Godin continued. “We believe this accomplishment demonstrates our commitment to meeting our goals, as set forth in our comprehensive business plan,” concluded Mr. Godin.

The NASDAQ Capital Market is the largest U.S. equities exchange, with approximately 3,200 member-companies. Nasdaq-listed companies are leaders across all areas of business including technology, retail, communications, financial services, transportation, media, and biotechnology.

“Being listed on the NASDAQ Capital Market will give Neptune greater exposure and should increase liquidity for its shareholders” stated Mr. Xavier Harland, Neptune Director, Finance.

“The Listing procedure was a rigorous process, specifically the exhaustive due diligence conducted by NASDAQ. Neptune has met and will remain subject to all the NASDAQ listing requirements,” added Mr. Godin.

About Neptune Technologies & Bioressources, Inc.
Neptune Technologies & Bioressources Inc. develops proprietary and potent health ingredients from underexploited marine biomasses, such as krill, with its patented extraction process (Neptune OceanExtract™). Using its proprietary process, Neptune Technologies & Bioressources Inc. is strategically positioning itself in the health and wellness market.

Natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the Company continues to demonstrate the immense beneficial effects of these products. The Company develops and markets new formulas and new products for specific applications in high growth markets such as the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets.